Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Blog
dkNET community events and announcements in June, 2022
Dear dkNET Community,
dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.
dkNET News
- Recordings and Slides are Now Available for the dkNET webinars "T Cell Antigen Discovery: Experimental and Computational Approaches," presented by Dr. Alok V. Joglekar on April 27, 2022: Recording; Slides.
- D-Challenge: dkNET is partnering with the(sugar)science again for D-Challenge this summer and fall. This is a collaborative bioinformatics challenge using online digital resources focused on Type 1 Diabetes. The D-Challenge is open to participants of all skill levels - from students without programming skills to bioinformaticians & data scientists. Registration will be opened in Spring 2022: https://dknet.org/about/blog/2425
- New tools added:
- CoffeeProt (RRID:SCR_022256) is an open-source software tool for correlation and functional enrichment of proteome-wide systems genetics. It analyzes genetic variants associated with protein networks and phenotypic traits. It uses proteomics data to perform correlation network analysis and annotates protein-protein interactions, subcellular localizations and drug associations.
- SigCom LINCS (RRID:SCR_022275) is a web server that serves over a million gene expression signatures processed, analyzed, and visualized from LINCS, GTEx, and GEO. It contains data and a metadata search engine for gene expression signatures.
- xHLA (RRID:SCR_022277) is a software tool for fast and accurate HLA typing from short-read sequence data. It iteratively refines mapping results at the amino acid level to achieve four-digit typing accuracy for both class I and II HLA genes, taking only 3 min to process 30× whole genome BAM files on a desktop computer.
- Polysolver (RRID:SCR_022278) is a software tool for HLA typing based on whole exome sequencing data, inferring alleles for three major MHC class I genes. It enables accurate inference of germline alleles of class I HLA-A, B and C genes and subsequent detection of mutations in these genes using inferred alleles as reference.
- OptiType (RRID:SCR_022279) is a software tool for precision HLA typing from next generation sequencing data.
- HLAscan (RRID:SCR_022281) is a software tool for the genotyping of HLA regions using next generation sequencing data. It performs alignment of reads to HLA sequences from the international ImMunoGeneTics project/human leukocyte antigen (IMGT/HLA) database.
- HLAminer (RRID:SCR_022282) is a software for HLA predictions from next generation shotgun sequence read data and supports direct read alignment and targeted de novo assembly of sequence reads. It is used for identifying HLA alleles directly from shotgun sequence datasets. It supports predictions from a variety of DNA sequencing technologies including those from Illumina, MGI, PacBio and Oxford Nanopore.
- HLA-LA (RRID:SCR_022283) is a software that implements the new graph alignment model for human leukocyte antigen, based on the projection of linear alignments onto variation graphs. It enables accurate HLA type inference from whole genome and whole exome Illumina data; from long-read Oxford Nanopore and Pacific Biosciences data and from genome assemblies.
- HLA-VBSeq (RRID:SCR_022284) is a software for accurate HLA typing at full resolution from whole genome sequencing data. It is used to estimate the most likely HLA types from high throughput sequencing data.
- HLA-HD (RRID:SCR_022285) is a software HLA typing algorithm for next generation sequencing data. It can accurately determine HLA alleles with 6-digit precision from NGS data (fastq format). RNA-Seq data can also be applied.
- arcasHLA (RRID:SCR_022286) is a software tool for high-resolution HLA typing from RNAseq. It provides fast and accurate in silico inference of HLA genotypes from RNA-seq.
Events in June 2022
Jun. 03-07, 2022
American Diabetes Association 82nd Scientific Sessions
Save the date for the American Diabetes Association’s 82nd Scientific Sessions in New Orleans, LA, June 3-7, 2022 at the Ernest N. Morial Convention Center.
We know you are eager to participate in-person, to network with colleagues, hear the latest scientific advances and groundbreaking research presentations, and experience the Exhibit and Poster Halls. ADA is currently planning a hybrid event.
Abstract Submission Due: January 10, 2022, at 5:00 PM ET.
More Information: https://professional.diabetes.org/scientific-sessions
Location: New Orleans, LA, USA
Jun. 08, 2022
23rd Annual Harvard Nutrition and Obesity Symposium: “The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets”
The Nutrition Obesity Research Center at Harvard (NORCH) is pleased to announce our 23rd Annual Symposium, entitled “The Neurobiology of Eating Behavior in Obesity: Mechanisms and Therapeutic Targets.” We have an excellent lineup of speakers, who will present new work on a wide range of topics including gut-brain communication, surgical and non-surgical interventions, appetite regulation, and obesity in an addiction framework. Click here to register now. We are expected a high volume of attendees and encourage you to secure your spot early. Additional event info and speaker information can be found on the event webpage. This event will be held virtually. All are welcome to attend! Registration is free for all attendees. Register now
Meeting Date: June 8, 2022, 8:30am to 4:30pm EST (5:30am to 1:30pm PST)
Jun. 10, 2022
Data Sharing and Reuse Seminar: "Creating a Just Genomic Data Science Community by Providing Resources at Community Colleges"
Dr. Rosa Alcazar will present "Creating a Just Genomic Data Science Community by Providing Resources at Community Colleges" at the monthly Data Sharing and Reuse Seminar on June 10, 2022 at 12 p.m. EDT. Genomic data science has become foundational to modern biology research. To create a just research community, we must provide sufficient resources to places that excel in serving people from underrepresented populations. While community colleges offer pathways for many who wouldn’t otherwise be able to attend college, they often lack the compute infrastructure, curriculum, and professional development necessary for instruction in rapidly changing fields. In partnership with a group of dedicated researchers and educators, we are building the Genomic Data Science Community Network (GDSCN) to provide resources accessible by anyone with an internet connection. Our vision is to share not only data but training and expertise irrespective of institutional affiliation breaking down barriers that create silos perpetuating a homogenized research community.
Seminar Date: June 10, 2022 at 9:00am PDT
More Information: https://datascience.nih.gov/news/june-data-sharing-and-reuse-seminar-2022
Jun. 10, 2022
PKD Research Resource Consortium: Jared J. Grantham Symposium 2022
To honor Dr. Jared Grantham in his retirement, the Kidney Institute at the University of Kansas Medical Center hosted the first Jared J. Grantham Symposium on May 7 - 9th, 2014 in Kansas City. Dr. Grantham's vision was to invite all of the Lillian Jean Kaplan award recipients to lead a forward-thinking and interactive forum to focus on future directions and innovations in polycystic kidney disease research. All twelve of the Kaplan Awardees were present at the inaugural symposium to give talks on their vision of " The Future of PKD Research." The Kidney Institute will continue to host the Grantham Symposium annually.
Meeting Date: June 10, 8:30 am – 12:30 pm CST [6:30 am– 11:30 am PST]
Passcode: 265761 | Webinar ID: 845 2478 8761
More Information: https://www.kumc.edu/research/kidney-institute/events/jared-j-grantham-symposium.html
Jun. 11-14, 2022
ENDO 2022
ENDO is the seminal meeting in hormone health and science, welcoming leading experts, researchers, and the most respected clinicians in the field as we share the latest developments in endocrine research and patient care. This year we will be offering registrants the option to attend our meeting in person or virtually, so you are able to participate as you prefer.
ENDO 2022 will provide the first opportunity to connect in person with your colleagues in more than two years. For more information about our program, registration, abstract submissions, awards, and more, please explore our new ENDO site.
Abstract Submission deadline extended to January 24, 2022
Conference Dates: June 11-14, 2022 in Atlanta, GA
More Information: https://endo2022.endocrine.org/
Location: Atlanta, GA, USA
Jun. 13, 2022
NIDDK Workshop Registration Deadline: Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases Workshop
The goal of this 1.5-day workshop will be to gather clinical and basic science investigators who are interested in diseases of the exocrine and/or endocrine pancreas and in achieving an understanding of how the two compartments interact in disease. This workshop will provide an opportunity for investigators in exocrine diseases to come together with those studying islets in diabetes as a means to foster interdisciplinary discussion and identify areas for advancement.
Abstract Submission Deadline: May 20, 2022
Workshop dates: June 29-30, 2022
Registration Deadline: June 13, 2022
More Information: https://dknet.org/about/dknetnews/2354
Jun. 13-15, 2022
European Islet Study Group Workshop
The aim of this Islet Study Group workshop is to encourage research on diabetes and support the rapid diffusion of acquired knowledge in the specific fields of the development of the pancreas and the beta cell, the function of the Langerhans islet, the regeneration of islet cells and the dangerous links between islets of Langerhans and diabetes. Talks will be held face-to-face as well as online. Slots are available for short talks. A poster session (face-to-face only) is also included in the programme.
Meeting dates: June 13th, 14th and 15th, 2022
Registration & Payment Deadline: May 13, 2022
Abstract Submission Deadline: April 4, 2022
More Information: https://eisg.sciencesconf.org/
Location: Strasbourg, France and virtual
Jun. 14, 2022
LIPIDMAPS Webinar: "Bacterial sphingolipids – discovery of cryptic pathways expands the ceramide inventory."
LIPIDMAPS Webinar: "Bacterial sphingolipids – discovery of cryptic pathways expands the ceramide inventory."
Webinar Date: June 14, 2022 at 5pm BST | 9am PDT | 12pm EDT
Presented by: Professor Dominic Campopiano
Dominic Campopiano is Chair of Industrial Biocatalysis in the School of Chemistry at the University of Edinburgh. He studied chemistry at the University of Glasgow (1984–88) then carried out his PhD studies in Chemistry at the University of Edinburgh under the supervision of Prof. Bob Baxter (1988–91). After post-doctoral stints with Prof. Bill Shaw in Biochemistry at the University of Leicester and in Chemistry at Edinburgh, he was appointed to a lectureship in 1998. He was promoted through the ranks of senior lecturer and reader before taking up his chair in 2015. He held a Royal Society of Edinburgh/Scottish Executive Personal Research Fellowship (2006) and was made a Fellow of the Royal Society of Chemistry (FRSC) in 2018.
More Information: https://www.lipidmaps.org/resources/webinars/24
Jun. 15, 2022
Abstract Submission Due: Neuroscience 2022
Neuroscience 2022 will be held in-person in San Diego, CA, November 12-16. SfN is also exploring options for a virtual presentation for those abstract presenters unable to attend the meeting in-person. More details will be available in May. Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall.
Abstract Submission Deadline: June 15, 2022
Advance Registration Deadline: October 3, 2022
Conference Dates: November 12-16, 2022
More Information: https://www.sfn.org/meetings/neuroscience-2022
Location: San Diego, CA, USA
Jun. 15, 2022
Type 1 Diabetes Consortium Webinar: The Islet Autoantibody Clinical Trial Enrichment Tool
The objectives of this webinar are to:
• provide an overview of the aggregated database and modeling analysis used to
provide the necessary evidence to support the qualification opinion
• discuss the rationale and methodology to generate the underlying synthetic data that
supports the clinical trial enrichment tool
• demonstrate use cases for how the Islet Autoantibody Clinical Trial Enrichment Tool
can enhance clinical trial enrichment for T1D prevention clinical studies, including a
‘live’ demonstration of the tool
Register at the link below.
Webinar Date: June 15, 2022 at 8:00-9:30AM PDT
More Information: https://c-path-org.zoom.us/webinar/register/3616496976993/WN_nhKubSO1R36JT7joS5jEIQ
Jun. 15, 2022
Obesity Journal Symposium Submission Due: Obesity Week
The preeminent international conference for obesity researchers and clinicians, ObesityWeek® is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy. Overcoming obesity requires multi-disciplinary approaches. This is the conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations. ObesityWeek® 2022 will be a hybrid conference.
Conference Dates: November 1-4, 2022
Obesity Journal Symposium Submission Deadline: June 15, 2022
More Information: https://obesityweek.org/
Jun. 15, 2022
Diabetes Research Center Virtual Seminar Series: "Intersection of prostaglandin E2 and GLP-1 signaling pathways to promote beta-cell identity, proliferation, and survival"
Virtual Seminar Series: "Intersection of prostaglandin E2 and GLP-1 signaling pathways to promote beta-cell identity, proliferation, and survival" on June 15, 2022 at 11:00AM PDT
Presenter: Maureen Gannon, PhD
Register here: https://redcap.vanderbilt.edu/surveys/?s=943LC3HD7CKPK9E3
More Information: https://twitter.com/vumcdiabetes/status/1525107877345497088
Jun. 19-24, 2022
2022 Immunometabolism Conference: Basic and Translational Cellular Metabolism in Immunity
To support this critical juncture in the young field of ‘immunometabolism,’ we are assembling international experts from academia and industry on the role of cellular metabolism in the programming of myeloid and lymphoid immune cells in immunity and disease. The conference will address emerging methods, findings, and paradigms. Molecular, cellular, animal, and human data will be presented, aiming to galvanize steps forward in the mechanistic understanding of how cellular metabolism programs immune responses, and how these insights may be therapeutically targeted. We expect to foment productive, high-level discussions and new collaborations, and to create a nurturing and supportive environment for early-career investigators and trainees who represent the next generation of scientists in this critical cross-disciplinary field.
Conference Dates: June 19 - 24, 2022
Application Submission Deadline: May 22, 2022
More Information: https://www.grc.org/immunometabolism-in-health-and-disease-conference/2022/
Location: Bryant University, Smithfield, RI 02917, USA
Jun. 19-22, 2022
14TH ANNUAL INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY OF HUMAN DISEASE
The SBHD conference series is a bi?national annual event initially launched by Peter Sorger and colleagues at Harvard Medical School in 2008 with its location alternating between the USA and Germany. SBHD 2022 will take place in Nashville, TN, USA, hosted by Vanderbilt University.
The Systems Biology of Human Disease (SBHD) conference focuses on systems biology approaches for the understanding, diagnosis, and therapy of human diseases. We look forward to welcoming top?class national and international scientists speaking on these highly up?to?date topics. Additionally, the SBHD has had a good tradition of including short and lightning talks, as well as extended poster sessions selected from submitted abstracts.
Conference Dates: June 19-22, 2022
Abstract Submission Deadline: May 2, 2022
Early registration Deadline: April 22, 2022
More Information: https://sbhdnashville.org/
Location: Nashville, TN, USA
Jun. 22, 2022
Vivli Webinar: How Vivli Promotes Discoverability of Partner Platforms and Repositories
In this webinar, Vivli will share how we work with our platform partners, including NIH Domain Repository partners, to enhance discoverability of their data. Vivli has recently been named a Generalist Repository as part of the NIH GREI initiative. A primary objective of the GREI initiative is to supplement the NIH domain-specific data repositories in their data sharing. This webinar will also cover how Vivli supports NIH-funded researchers in advance of the NIH Data Management and Sharing policy that begins in January 2023.
Meeting Date: June 22, 2022 at 8:00am PDT
More Information: https://us06web.zoom.us/webinar/register/WN_0TJUpPgdTtWRabA5V7Ip3A
Jun. 24-25, 2022
PKD Connect Conference
The PKD Connect Conference (PKDCON) is an annual event that brings together every part of the PKD community—from patients and caregivers to researchers and physicians—to provide education, research updates, resources, and networking opportunities.
Virtual and free to attend this year, PKDCON 2022 will provide a rich educational experience, meaningful interactions with other participants, and engaging Q&A sessions with faculty. Join us for our second virtual conference June 24 – 25.
Conference dates: June 24-25, 2022
Abstract Deadline: April 11, 2022
More Information: https://pkdcure.org/conference/
Jun. 28, 2022
FASEB DataWorks! Challenge Registration Deadline
The Federation of American Societies for Experimental Biology (FASEB) and the National Institutes of Health (NIH) are championing a bold vision of data sharing and reuse. The DataWorks! Prize fuels this vision with an annual challenge that showcases the benefits of research data management while recognizing and rewarding teams whose research demonstrates the power of data sharing or reuse practices to advance scientific discovery and human health. We are seeking new and innovative approaches to data sharing and reuse in the fields of biological and biomedical research.
To incentivize effective practices and increase community engagement around data sharing and reuse, the 2022 DataWorks! Prize will distribute up to 12 monetary team awards. Submissions will undergo a two-stage review process, with final awards selected by a judging panel of NIH officials. The NIH will recognize winning teams with a cash prize, and winners will share their stories in a DataWorks! Prize symposium.
Registration Deadline: June 28, 2022
Submission Deadline: July 19, 2022
More Information: https://www.herox.com/dataworks
Jun. 29-Jul. 01, 2022
8th European Workshop on Lipid Mediators
This biennial workshop is primarily addressed to scientists interested in the field of bioactive lipid mediators. Scientists from across and outside Europe will share their expertise on the biochemistry, molecular biology and physiology of lipids as signaling molecules, as well as their involvement in inflammation, and their specific roles in several disease conditions.
Workshop Dates: June 29th - July 1st, 2022
More Information: https://workshop-lipid.eu/
Location: Karolinska Institute, Stockholm, Sweden
Jun. 29-30, 2022
NIDDK Integrated Physiology of the Exocrine and Endocrine Compartments in Pancreatic Diseases Workshop
The goal of this 1.5-day workshop will be to gather clinical and basic science investigators who are interested in diseases of the exocrine and/or endocrine pancreas and in achieving an understanding of how the two compartments interact in disease. This workshop will provide an opportunity for investigators in exocrine diseases to come together with those studying islets in diabetes as a means to foster interdisciplinary discussion and identify areas for advancement.
Abstract Submission Deadline: May 20, 2022
Workshop dates: June 29-30, 2022
Registration Deadline: June 13, 2022
More Information: https://dknet.org/about/dknetnews/2354
Location: Bethesda, MD, USA
Jun. 29, 2022
NIDDK Pre-Application Webinar for Institutional Network Awards for Research Training
NIDDK’s Division of Kidney, Urologic, and Hematologic Diseases (KUH) is hosting a second preapplication webinar to address questions related to PAR-20-220 NIH external link Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed).
Per NOT-DK-20-023 NIH external link, PAR-20-220 is offered in lieu of KUH participation in PA-20-142.
Meeting Objectives:
give programmatic information about the FOA
provide information about the application review process
answer questions submitted by you and prospective applicants
Webinar Date: July 29, 2022 12:00 - 1:00 p.m. EDT [9:00 - 10:00 a.m. PDT]
More Information: https://www.niddk.nih.gov/news/meetings-workshops/2022/pre-application-webinar-institutional-network-awards-research-training
Jun. 30, 2022
Registration Due: NIDDK Clinical Trials in Pancreatitis Meeting
Recurrent acute and chronic pancreatitis are characterized by pain, disability, and late-stage complications. No U.S. Food and Drug Administration (FDA)–approved drugs currently exist to treat these diseases, but interest in developing therapeutic strategies and clinical trial guidelines has increased, both among the investigative community and in the FDA. This 1-day workshop will feature discussions to help attendees understand the principles and requirements of clinical trials for treatment approaches for these diseases.
Meeting Dates: July 20, 2022
Registration Deadline: June 30, 2022
More Information: https://www.niddk.nih.gov/news/meetings-workshops/2022/clinical-trials-pancreatitis
Location: Pittsburgh, PA, USA
Funding Opportunities Information and Deadlines in June 2022
Jun. 01, 2022
NIDDK Funding Opportunity Application Due: New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not Allowed)
The New Investigator Gateway Award in T1D Research is designed to support a robust pipeline of innovative projects and talented new investigators in T1D research. In addition to providing support for preliminary research, the Gateway program provides an opportunity for new Program Directors/Principal Investigators (PD/PIs) to pursue their studies within the intellectual environment of a select number of large, ongoing collaborative research programs. Embedding awardees within an established scientific framework in each of these consortia will provide unique opportunities for New and Early Stage Investigators to increase their understanding of key questions in the field, to network, and to establish unique and potentially long-lasting collaborations that will propel their careers forward. Bringing New and Early Stage Investigators into existing collaborative research networks will also benefit the networks by providing new ideas and perspectives.
Letter of Intent Deadline: May 1, 2022 and February 20, 2023
Application Deadline (New Application): June 1, 2022 and March 20, 2023
More Information: https://dknet.org/about/dknetnews/2379
Jun. 01, 2022
NIDDK Funding Opportunity Application Due: High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The interdisciplinary approach encouraged by this FOA is envisioned to generate a research resource and/or foster discovery-based or hypothesis-generating science that can have a significant impact on the broader scientific community. This FOA seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that will advance the area in significant ways designed to accelerate scientific progress in the understanding, treatment, and prevention of diseases within the mission of the NIDDK.
Letter of Intent Deadline: Six weeks prior to the application due date.
Application Deadline: June 01, 2022; November 02, 2022
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-069.html
Jun. 01, 2022
NIDDK Funding Opportunity Application Due: Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Epidemiologic Studies of Diabetes Incidence and Severity and Its Potential Association with COVID-19
NIDDK is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for epidemiologic studies of diabetes incidence and severity and its potential association with coronavirus disease 2019 (COVID-19) and the causative virus SARS-CoV-2.
Application Deadline: June 1, 2022
More Information: https://grants.nih.gov/grants/guide/notice-files/NOT-DK-22-017.html
Jun. 02, 2022
NIH Funding Opportunity Application Due: HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this FOA is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. Research supported by this FOA must include rigorous validation studies to demonstrate the robustness of the target as a pain treatment target. This will lower the risk of adopting the target in translational projects to develop small molecules, biologics, natural substances, or devices that interact with this target for new pain treatments. Translational research to develop new medical devices is not the focus of this FOA. Basic science studies of pain and related systems in the body are responsive to this FOA and are encouraged in the context of novel pain therapeutic target discovery.
Letter of Intent Deadline: 30 days prior to the application due date.
Application Deadline: March 02, 2022, June 02, 2022, October 04, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-ns-22-034.html
Jun. 05, 2022
NIH Funding Opportunity Application Due: Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional)
This initiative will support innovative research to develop, test and evaluate multi-level/multi-component strategies (including models of health care) to effectively adapt and implement comprehensive clinical care for individuals with Type 2 diabetes mellitus from populations with health disparities concordant with recommended and evidence-based guidelines.
Letter of Intent due 30 days prior to application.
Application Deadline(s): June 05, 2022, October 05, 2022, February 05, 2023, (...)
More Information: https://grants.nih.gov/grants/guide/pa-files/pa-21-232.html
Jun. 05, 2022
NIDDK Funding Opportunity Application Due: Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
The Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) program is intended to promote innovative, high quality, interdisciplinary research relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK invites investigator-initiated research project grant applications (R01s) in specific areas of basic, translational, or clinical research in specific benign urologic conditions and diseases where needs and opportunities for progress are particularly timely. As such, research topics of interest will change over time to take advantage of emerging opportunities. The research topic area previously supported by the SUITOR program, urinary incontinence, will now transition to neurourology, as described below.
Application Deadline: February 5, 2022; June 5,2022 (...)
More Information: https://grants.nih.gov/grants/guide/pa-files/pas-22-074.html
Jun. 05, 2022
NIH Funding Opportunity Application Due: Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI). Investigator-initiated research project grant applications (R01s) in specific areas of basic and early translational hematology research are invited to this program that supports growth in the nonmalignant hematology research domain. Specific emerging topics that are at the leading edge of the field will change over time and will be updated regularly through the NIH Guide to Grants and Contracts and hyperlinked to this FOA.
Application Deadline: February 05, 2022; June 05, 2022; October 05, 2022
More Information: https://grants.nih.gov/grants/guide/pa-files/pas-22-096.html
Jun. 08, 2022
SMaHT Program Funding Opportunities Letter of Intent Due: 5 Awards
Somatic Mosaicism Across Human Tissues (SMaHT) Funding Opportunities
Letter of Intent Deadline: June 8, 2022
Application Deadline: July 8, 2022
More Information: https://commonfund.nih.gov/smaht/fundingopportunities
Jun. 14, 2022
NIDDK Funding Opportunity Letter of Intent Due: Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later stage therapeutics development and preclinical efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to diabetes and other endocrine and metabolic diseases, liver and other digestive diseases, nutritional disorders, obesity, kidney and urological diseases, and hematologic diseases. Additional information concerning programmatic areas at NIDDK is available at www.niddk.nih.gov/research-funding/research-programs and applicants are strongly encouraged to discuss research priorities with the Scientific Contacts for each division.
The objective of this FOA is to stimulate early-stage preclinical validation of therapeutic leads (that need not be finalized therapeutics, henceforth called "therapeutic leads") such as small molecules or non-viral biologics that are not currently a focus within the biotechnology and pharmaceutical industries. It is expected that there is significant novelty in the target, small molecule, or non-viral biologic and in how the resulting therapeutic would differentiate from existing therapies. This must be articulated clearly in the application. It is not intended to support research focused on understanding normal biology, disease processes, generating lists of putative new targets, identifying new therapeutic uses for existing compounds, or identifying mechanism of action for therapeutic leads.
Letter of Intent Deadline: June 14, 2022, ; October 14, 2022, (...)
Application Deadline: July 14, 2022 ; November 14, 2022, (...)
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-111.html
Jun. 15, 2022
IIDP Funding Opportunity Application Due: Islet Award Initiative
The IIDP Islet Award Initiative is intended to advance research in human islet biology by facilitating the ability of researchers to access human islets for high impact and novel research studies. The number of IIDP Islet Awards funded under this initiative will be determined in any single year based on available resources but will average 3-4 awards per submission date.
Application Deadline: June 15, 2022
More Information: https://iidp.coh.org/Investigators/Islet-Award-Initiative
Jun. 15, 2022
NIH Funding Opportunity Application Due: Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services (e.g. cancer screening) that may have dropped off amidst the ongoing COVID pandemic are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.
Letter of Intent Deadline: 30 days prior to application due date
Application Deadline(s): June 15, 2022; October 05, 2022; February 05, 2023 (...)
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-105.html
Jun. 21, 2022
NIDDK Funding Opportunity Application Due: NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research
To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:
Courses for Skills Development
Mentoring Activities
This R25 program encourages professional societies supporting the NIDDK mission areas to develop educational programs aimed at recruiting talented junior faculty from diverse backgrounds, including those from groups underrepresented in biomedical, behavioral, clinical, and social sciences research. Professional societies should propose an educational program that includes a diversity recruitment plan that would enhance the diversity of the the candidate pool for available positions in the organization's scientific workforce, including recruitment of individuals from groups historically underrepresented in the organization's programs and leadership.
Letter of Intent Deadline: May 21, 2022
Application Deadline: June 21, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-004.html
Jun. 22, 2022
NIH Funding Opportunity Application Due: Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)
The purpose of the Funding Opportunity Announcement is to invite applications to identify and characterize microbial metabolites that will establish causal associations between microbial metabolism and host health and disease. Data acquired through this initiative will be used to create a knowledgebase of microbial metabolites and associated functions that will be provided to the research community. Development of the database and knowledge portal for these awards will be supported under a separate initiative: RFA-DK-21-014, Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (Clinical Trial Not Allowed).
Letter of Intent Deadline: September 20, 2021; May 20, 2022; September 20, 2022; May 19, 2023 and September 19, 2023
Application Deadline: October 20, 2021; June 22, 2022; October 20, 2022; June 22, 2023; October 19, 2023
More Information: https://grants.nih.gov/grants/guide/pa-files/par-21-253.html
Jun. 24, 2022
NIH Funding Opportunity Application Due: Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers.
The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.
Application Deadline: June 24, 2022
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-078.html
Jun. 27, 2022
NIH Funding Opportunity Response Due: Request for Public Comments on DRAFT Supplemental Information to the NIH Policy for Data Management and Sharing: Protecting Privacy When Sharing Human Research Participant Data
NIH is seeking public comments on draft supplemental information to the NIH Policy for Data Management and Sharing to address privacy considerations. This information is not intended to provide a guide for compliance with regulatory requirements, but is rather a set of principles, best practices, and points to consider for creating a robust framework for protecting the privacy of research participants when sharing data under the NIH Policy for Data Management and Sharing. After considering public comments on this draft supplemental information, NIH intends to issues revised supplemental information in 2022.
Response Deadline: June 27, 2022
More Information: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-131.html
Jun. 28, 2022
NIDDK Funding Opportunity Letter of Intent Due: Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications for Cystic Fibrosis (CF) Research and Translation Core Centers. CF Research and Translation Core Centers are designed to support both basic and clinical research on Cystic Fibrosis. CF Research and Translation Core Centers support three primary research-related activities: Research Core services; a Pilot and Feasibility program; and an Administrative Core with an enrichment program. Core Centers provide shared resources to support research to develop and test new therapies for CF and to foster collaborations among institutions with a strong existing research base in CF. The NIDDK currently supports seven CF Research and Translation Centers located at institutions with documented programs of research excellence in basic and clinical CF Research.
Letter of Intent Deadline: June 28, 2022
Application Deadline: July 28, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-011.html
Jun. 29, 2022
NIH Funding Opportunity Letter of Intent Due: Education Program on Translational Devices (R25 Clinical Trial Not Allowed)
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.
To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:
Courses for Skills Development
This FOA invites Research Education Grant (R25) applications to develop and implement a short course focused on (1) steps required for successful neural medical device development, translation, and commercialization, (2) common technical and strategic challenges, and (3) best-practices and resources for each stage in the process. Applicants may choose to include a plan for extended engagement opportunities for participants to continue to interact with and obtain guidance from faculty members after the conclusion of the course. The short course should address a broad audience, including senior post-doctoral fellows, independent academic researchers, clinician scientists, and small business entrepreneurs interested in developing, translating, and/or commercializing medical devices to diagnose or treat a nervous system disorder.
Letter of Intent Deadline: June 29, 2022
Application Deadline: July 29, 2022
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-146.html
About
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.
Recent News Entries
Contact Us
Email: info_at_ dknet.org
